Literature DB >> 6245150

Detection of hepatitis A virus in the feces of patients with naturally acquired infections.

A G Coulepis, S A Locarnini, N I Lehmann, I D Gust.   

Abstract

A prospective study was carried out on 200 patients admitted to Fairfield Hospital, Melbourne, Australia, with acute hepatitis A to determine the frequency with which virus could be detected in their feces. Evidence of infection with hepatitis A virus (HAV) was obtained by detecting IgM specific for HAV in a single serum sample or by demonstrating a rising titer of antibody in paired sera by solid-phase radioimmunoassay. HAV was detected in the feces of 59 of the 200 patients by solid-phase radioimmunoassay and immune electron microscopy. When patients were admitted within one week of the onset of dark urine, 45% were found to be shedding HAV, whereas only 11% of specimens obtained from patients admitted during the second week contained virus. HAV was not detected in fecal specimens collected more than 14 days after the onset of dark urine. These findings suggest that patients admitted to hospital with hepatitis A may still be infectious and that appropriate precautions against fecal contamination should be maintained.

Entities:  

Mesh:

Year:  1980        PMID: 6245150     DOI: 10.1093/infdis/141.2.151

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Detection of hepatitis A virus and antibody by solid-phase radioimmunoassay and enzyme-linked immunosorbent assay with monoclonal antibodies.

Authors:  A G Coulepis; M F Veale; A MacGregor; M Kornitschuk; I D Gust
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

Review 2.  Towards a hepatitis A vaccine. A review.

Authors:  B N Anderson; A G Coulepis; I D Gust
Journal:  J Hyg (Lond)       Date:  1984-10

3.  Evidence that the genome of hepatitis A virus consists of single-stranded RNA.

Authors:  A G Coulepis; G A Tannock; S A Locarnini; I D Gust
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

4.  Hepatitis A-virus in cell culture. IV. Comparison of cell-culture-produced HAV with stool-derived HAV in diagnostic test systems.

Authors:  B Flehmig; M Pfisterer; A Vallbracht
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

5.  Monoclonal antibodies against hepatitis A virus.

Authors:  A MacGregor; M Kornitschuk; J G Hurrell; N I Lehmann; A G Coulepis; S A Locarnini; I D Gust
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

6.  [Virus-induced liver diseases in man. III. Chronic hepatitis].

Authors:  J Eisenburg
Journal:  Naturwissenschaften       Date:  1983-02

7.  Detection of hepatitis A virus in the stools of healthy people from endemic areas.

Authors:  P De Filippis; M Divizia; A Mele; B Adamo; A Panà
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

8.  Serological hepatitis A virus infections and ratio of clinical to serological infections in a controlled trial of pre-exposure prophylaxis with immune serum globulin.

Authors:  J D Kark; S Bar-Shany; S Shor; L Merlinski; E Nili
Journal:  J Epidemiol Community Health       Date:  1985-06       Impact factor: 3.710

9.  Does mutation of hepatitis A virus exist in North India?

Authors:  Zahid Hussain; Syed A Husain; Syed T Pasha; Ranjana Anand; Abdullah Chand; Sunil K Polipalli; Shabeena Rehman; Premashis Kar
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

10.  Viral hepatitis and the surgeon.

Authors:  G Y Minuk; A J Cohen; N Assy; M Moser
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.